Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 10,000 | |||
25 mg | 在庫あり | ¥ 15,500 | |||
50 mg | 在庫あり | ¥ 19,500 | |||
100 mg | 在庫あり | ¥ 32,500 | |||
200 mg | 在庫あり | ¥ 42,000 | |||
500 mg | 在庫あり | ¥ 68,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 11,000 |
説明 | Seratrodast (ABT-001) (INN), a thromboxane A2 (TXA2) receptor (TP receptor) antagonist, is mainly used in the therapy of asthma. It was the first TP receptor antagonist developed as an anti-asthmatic drug and attained marketing qualification in Japan in 1997. |
別名 | AA 2414, ABT-001 |
分子量 | 354.44 |
分子式 | C22H26O4 |
CAS No. | 112665-43-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (141.07 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Seratrodast 112665-43-7 DNA Damage/DNA Repair GPCR/G Protein Immunology/Inflammation Metabolism Neuroscience Prostaglandin Receptor COX PPAR Inhibitor inhibit AA 2414 ABT001 ABT-001 ABT 001 AA-2414 AA2414 inhibitor